Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study

INSERM, UMRS 943, Paris F-75013, France; UPMC Univ Paris 06, UMRS 943, Paris F-75013, France; Department of Infectious Diseases, AP-HP, Pitie-Salpetriere Hospital, Paris, France; Department of Virology, AP-HP, Pitie-Salpetriere Hospital, Paris, France; Department of Infectious Diseases, AP-HP, Necker Hospital, Paris, France; Rheumatology Department, AP-HP, Paris-Descartes University, Cochin Hospital, Paris, France; Department of Infectious Diseases, AP-HP, Tenon Hospital, Paris, France; Department of Infectious Diseases, AP-HP, Bordeaux Hospital, Bordeaux, France; Laboratory of Toxicology and Pharmacokinetics, AP-HP, Bichat-Claude Bernard Hospital, Paris, France